These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 24321897

  • 21. Surface ECG f Wave Analysis of Dofetilide Drug Effect in the Atrium.
    Raygor VP, Ng J, Goldberger JJ.
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):644-8. PubMed ID: 25711372
    [Abstract] [Full Text] [Related]

  • 22. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 23. Maintenance of sinus rhythm and recovery of atrial mechanical function after cardioversion with bepridil or in combination with aprindine in long-lasting persistent atrial fibrillation.
    Fujiki A, Tsuneda T, Sakabe M, Nakagawa K, Mizumaki K, Hirai T, Inoue H.
    Circ J; 2004 Sep; 68(9):834-9. PubMed ID: 15329504
    [Abstract] [Full Text] [Related]

  • 24. Ibutilide in persistent atrial fibrillation refractory to conventional cardioversion methods.
    Naegeli B, Straumann E, Bertel O.
    Int J Cardiol; 2005 Mar 18; 99(2):283-7. PubMed ID: 15749188
    [Abstract] [Full Text] [Related]

  • 25. Short- and long-term clinical predictors of pharmacological cardioversion of persistent atrial fibrillation by dofetilide: A retrospective cohort study of 160 patients.
    Hassan Virk HU, Qureshi WT, Makkar N, Bastawrose J, Souvaliotis N, Aziz J, Aziz E.
    Clin Cardiol; 2017 Jul 18; 40(7):474-479. PubMed ID: 28295387
    [Abstract] [Full Text] [Related]

  • 26. Comparison of Direct Current Synchronized Cardioversion to Ibutilide-Guided Catheter Ablation for Long-Term Sinus Rhythm Maintenance After Isolated Pulmonary Vein Isolation of Persistent Atrial Fibrillation.
    Wang M, Zhao Q, Ding W, Cai S.
    Am J Cardiol; 2017 Jun 15; 119(12):1997-2002. PubMed ID: 28501100
    [Abstract] [Full Text] [Related]

  • 27. Potentially modifiable factors of dofetilide-associated risk of torsades de pointes among hospitalized patients with atrial fibrillation.
    Naksuk N, Sugrue AM, Padmanabhan D, Kella D, DeSimone CV, Kapa S, Asirvatham SJ, Lee HC, Ackerman MJ, Noseworthy PA.
    J Interv Card Electrophysiol; 2019 Mar 15; 54(2):189-196. PubMed ID: 30353374
    [Abstract] [Full Text] [Related]

  • 28. Acute conversion of persistent atrial fibrillation during dofetilide initiation.
    Cotiga D, Arshad A, Aziz E, Joshi S, Koneru JN, Steinberg JS.
    Pacing Clin Electrophysiol; 2007 Dec 15; 30(12):1527-30. PubMed ID: 18070309
    [Abstract] [Full Text] [Related]

  • 29. Poor maintenance of sinus rhythm after electrical cardioversion of patients with atrial fibrillation or flutter: a 5-year follow-up of 268 consecutive patients.
    Dahlin J, Svendsen P, Gadsbøll N.
    Scand Cardiovasc J; 2003 Dec 15; 37(6):324-8. PubMed ID: 14668181
    [Abstract] [Full Text] [Related]

  • 30. Role of dofetilide in patients with atrial fibrillation. Insights from the Symptomatic Atrial Fibrillation Investigative Research on Dofetilide (SAFIRE-D) study.
    Singh SN.
    Card Electrophysiol Rev; 2003 Sep 15; 7(3):225-8. PubMed ID: 14739718
    [Abstract] [Full Text] [Related]

  • 31. Does conversion and prevention of atrial fibrillation enhance survival in patients with left ventricular dysfunction? Evidence from the Danish Investigations of Arrhythmia and Mortality ON Dofetilide/(DIAMOND) study.
    Pedersen OD, Brendorp B, Elming H, Pehrson S, Køber L, Torp-Pedersen C.
    Card Electrophysiol Rev; 2003 Sep 15; 7(3):220-4. PubMed ID: 14739717
    [Abstract] [Full Text] [Related]

  • 32. Single dose of ibutilide for conversion of persistent atrial fibrillation after radiofrequency ablation.
    Hou Y, Fang PH, Liu J, Li XF, Hu JQ, Zhang S.
    Chin Med J (Engl); 2011 Mar 15; 124(5):710-3. PubMed ID: 21518563
    [Abstract] [Full Text] [Related]

  • 33. Atrial fibrillation recurrence after internal cardioversion: prognostic importance of electrophysiological parameters.
    Biffi M, Boriani G, Bartolotti M, Bacchi Reggiani L, Zannoli R, Branzi A.
    Heart; 2002 May 15; 87(5):443-8. PubMed ID: 11997417
    [Abstract] [Full Text] [Related]

  • 34. Prevalence and predictors of persistent sinus rhythm after elective electrical cardioversion for atrial fibrillation.
    Castrichini M, Restivo L, Fabris E, Massa L, Di Meola R, Beltrame D, De Luca A, Korcova R, Milo M, Sinagra G.
    J Cardiovasc Med (Hagerstown); 2021 Aug 01; 22(8):626-630. PubMed ID: 33882536
    [Abstract] [Full Text] [Related]

  • 35. Dofetilide: a class III anti-arrhythmic drug for the treatment of atrial fibrillation.
    Torp-Pedersen C, Brendorp B, Køber L.
    Expert Opin Investig Drugs; 2000 Nov 01; 9(11):2695-704. PubMed ID: 11060831
    [Abstract] [Full Text] [Related]

  • 36. Safety of oral dofetilide for rhythm control of atrial fibrillation and atrial flutter.
    Abraham JM, Saliba WI, Vekstein C, Lawrence D, Bhargava M, Bassiouny M, Janiszewski D, Lindsay B, Militello M, Nissen SE, Poe S, Tanaka-Esposito C, Wolski K, Wilkoff BL.
    Circ Arrhythm Electrophysiol; 2015 Aug 01; 8(4):772-6. PubMed ID: 26063741
    [Abstract] [Full Text] [Related]

  • 37. Longitudinal QTc stability and impact of baseline cardiac rhythm on discharge dose in dofetilide-treated patients.
    Khan ZA, LaBreck ME, Luli J, Roberts C, Smith A, El-Zein R, Tyler JD, Fu EY, Billakanty SR, Amin AK, Chopra N.
    J Cardiovasc Electrophysiol; 2022 Jun 01; 33(6):1281-1289. PubMed ID: 35362175
    [Abstract] [Full Text] [Related]

  • 38. Incidence of atrial fibrillation in patients with either heart failure or acute myocardial infarction and left ventricular dysfunction: a cohort study.
    Schmiegelow MD, Pedersen OD, Køber L, Seibæk M, Abildstrøm SZ, Torp-Pedersen C.
    BMC Cardiovasc Disord; 2011 May 14; 11():19. PubMed ID: 21569543
    [Abstract] [Full Text] [Related]

  • 39. Intravenous magnesium sulfate enhances the ability of dofetilide to successfully cardiovert atrial fibrillation or flutter: results of the Dofetilide and Intravenous Magnesium Evaluation.
    Coleman CI, Sood N, Chawla D, Talati R, Ghatak A, Kluger J, Dofetilide and Intravenous Magnesium Evaluation (DIME) Investigators.
    Europace; 2009 Jul 14; 11(7):892-5. PubMed ID: 19351630
    [Abstract] [Full Text] [Related]

  • 40. Persistent atrial fibrillation: a population based study of patients with their first cardioversion.
    Lehto M, Kala R.
    Int J Cardiol; 2003 Dec 14; 92(2-3):145-50. PubMed ID: 14659845
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.